Table 1.
Characteristics of the Patients With and Without Atherosclerosis.
| Atherosclerosis* N = 744 | No Atherosclerosis N = 1404 | P Value | |
|---|---|---|---|
| Age (mean) | 77.51 ± 9.04 | 75.68 ± 10.10 | <.001 |
| NIHSS at admission (mean) | 8.96 ± 6.78 | 8.10 ± v6.76 | .005 |
| Sex, male | 407 (54.7%) | 584 (41.6%) | <.0001 |
| Diabetes | 236 (31.7%) | 244 (17.4%) | <.0001 |
| Statins at admission | 262 (35.2%) | 322 (22.9%) | <.0001 |
| Hypertension | 652 (87.6%) | 1029 (73.3%) | <.0001 |
| Hyperlipidemia | 342 (46.0%) | 378 (26.9%) | <.0001 |
| Paroxysmal AF | 305 (41.0%) | 621 (44.2%) | .169 |
| History stroke/TIA | 237 (31.5%) | 328 (23.4%) | <.0001 |
| Current smoker | 79 (10.6%) | 124 (8.8%) | .188 |
| Alcoholism | 56 (7.5%) | 85 (6.0%) | .200 |
| Pacemaker | 70 (9.4%) | 80 (5.7%) | .002 |
| Congestive heart failure | 193 (25.9%) | 176 (12.5%) | <.0001 |
| Leukoaraiosis | 394 (52.9%) | 695 (49.5%) | .145 |
| Hemorrhagic transformation (24-72 h) | 81 (10.9%) | 157 (11.2%) | .885 |
| Oral anticoagulant therapy after index event | 570 (76.6%) | 1190 (84.7%) | <.0001 |
| DOAC therapy after index event | 344 (46.2%) | 869 (61.9%) | <.0001 |
| Aspirin after index event | 120 (16.1%) | 120 (8.5%) | <.0001 |
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; AF, atrial fibrillation; TIA, transient ischemic attack.